Source comparison
BPC-157 with Alcohol Safety: [Type] Comparison
Hepatic enzyme demand Minimal. Peptide fragments processed by hepatic peptidases at low enzymatic cost High. ADH and ALDH operate near capacity during ethanol clearance (7–10g/hour) Increased. Both require overlapping hepatic enzyme activity, creating potentia
This comparison does not assign a generated winner or score.
- Hepatic enzyme demand
- Minimal. Peptide fragments processed by hepatic peptidases at low enzymatic cost
- High. ADH and ALDH operate near capacity during ethanol clearance (7–10g/hour)
- Increased. Both require overlapping hepatic enzyme activity, creating potential competition for metabolic resources
- Risk unquantified. No trials measure enzyme saturation or clearance kinetics when both are present
- Gastrointestinal impact
- Animal models suggest gastric cytoprotection and mucosal healing (J Physiol Pharmacol, 2011)
- Disrupts gastric barrier, increases intestinal permeability, impairs mucosal defence
- Contradictory. Alcohol may counteract BPC-157's hypothesised protective effects on GI lining
- Unknown whether protective peptide mechanisms persist under alcohol-induced oxidative stress
- Oxidative stress
- No oxidative stress reported in animal studies
- Produces ROS via acetaldehyde formation and CYP2E1 induction. Accelerates hepatocyte damage
- Additive oxidative burden on liver cells if peptide metabolism and ethanol detox occur simultaneously
- No human data quantifying oxidative marker levels (SOD, GSH, MDA) under combined exposure
- Half-life and clearance
- Short plasma half-life (estimated <4 hours based on peptide structure). Rapid renal excretion
- Metabolised at 7–10g/hour. Predictable elimination kinetics
- Potential delay in peptide fragment clearance if hepatic enzymes prioritise ethanol detox
- Zero pharmacokinetic studies exist. Clearance delay is theoretical, not measured